Steven Cohen Homology Medicines, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $1.47 Million - $2.46 Million	-148,074 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $1.79 Million - $2.86 Million	148,074 New	148,074 $2.25 Million
Q3 2019 Nov 15, 2019	SELL	$14.74 - $22.28 $3.01 Million - $4.55 Million	-204,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $3.75 Million - $6.2 Million	204,200 New	204,200 $4 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.